Matteo Lambertini, MD PhD
@matteolambe
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
Presented today at #SABCS23 and published in @JAMA_current results of our study showing the feasibility and safety of #pregnancy after #BreastCancer in young #BRCA carriers @OncoAlert @SABCSSanAntonio @AACR @UniGenova @SanMartino_Ge #bcsm Link here: jamanetwork.com/journals/jama/…
The super @myESMO course in medical #oncology for medical students had officially started!!! Great contribution by #ESMOYOC led by @Rodrosb…really special and grateful to be here with @AndresC27622123 @DrJonLim @kfoury_maria 🤩😍 @OncoAlert @UniGenova
📽️ At #ESMOBreast25 we had the chance to speak with @matteolambe from the @UniGenova, to discuss the key insights from the session he co-chaired on survivorship, sex and side effects. hubs.ly/Q03xqR0y0
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 18-24, 2025 👉REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: 🫁🧬 ✅News From Industry: FLAURA2 Update #NSCLC 🫁 ✅Exercise in met #ProstateCancer ✅Surgery🆚RT☢️in Prostate…
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER) buff.ly/UrXfLEu In this open-label, phase II trial of pretreated HER2-positive advanced #BreastCancer , trastuzumab plus…
Out in @IJGConline the @ESGO_society #INCIP guidelines for the management of patients with gynecological #cancers during #pregnancy @UniGenova @OncoAlert @ElsevierNews @Scopus @sciencedirect @ElsevierConnect Free link for download: urlsand.esvalabs.com/?u=https%3A%2F…
Check out our interview with @matteolambe to hear about his key insights from the session he co-chaired on survivorship, sex and side effects at #ESMOBreast25 >>> hubs.ly/Q03xqWLv0
The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week July 11-17, 2025 👉REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: ✅TALAPRO2 in #ProstateCancer ✅Geriatric Assessment 👴 ✅Molecular Landscape of Non Clear Cell Renal Carcinoma…
Dear Colleagues, A warm Congratulations to Dr. @SimitSapkota , Medical Oncologist. Kathmandu Cancer Center, Nepal🇳🇵 Today we had the pleasure to participate in the "Training on research Methodology for Oncology Professionals " Program, a program held at the Kathmandu Cancer…
Presented at #ESMO24 by @fedrophd and now out in @JCO_ASCO evidence from the #POSITIVE trial on feasibility and safety of #breastfeeding after HR+ early #BreastCancer @OncoAlert @AnnPartridgeMD @ASCO ascopubs.org/doi/abs/10.120…
Thank you for a brilliant final, Jannik and Carlos 👏 #Wimbledon
Viviamo nell'era in cui il trofeo di Wimbledon è tra le mani di un tennista italiano 🇮🇹🥹🏆 #EurosportTennis #Wimbledon #Sinner
Questo punto è qualcosa di pazzesco per atletismo, velocità di esecuzione e potenza. Due giocatori formidabili.
Per la prima volta in 138 edizioni del torneo, un italiano ha vinto il torneo singolare di Wimbledon 🇮🇹💫🏆 #Tennis #Wimbledon #Sinner
Forza @delmastro_lucia INSIEME per @AIOMtweet
Forza @delmastro_lucia…tutti #INSIEME…per @AIOMtweet !!!! @OncoAlert @UniGenova @Lucarecco @Poggio_Fra @M_Tagliamento @DSoldatoMD @CarloGenova5 @MRazeti @ChiaraMolinelli @boutrosand
Jannik Sinner's name is etched into history forever 🏆 #Wimbledon
✍️ 2025 J. Sinner A new name is etched into #Wimbledon history ✨
Il Primo 🇮🇹 Jannik Sinner is Italy's first singles champion at #Wimbledon
Yes….we made it !!!!! 🇮🇹🔝🤩🥳😍❤️
Jannik Sinner is a Wimbledon champion 🇮🇹 The world No.1 defeats Carlos Alcaraz 4-6, 6-4, 6-4, 6-4 to win the 2025 Gentlemen's Singles Trophy 🏆 #Wimbledon